...on new kidney cancer drugs in the U.K. will soon be lifted, the Guardian reports. Of four meds that the National Institute for Health and Clinical Excellence called too expensive for National Health Service use, at least half will be approved--and...
...when it was announced that her cancer had returned and spread. No doubt headlines over decisions by the National Institute for Health and Clinical Excellence (Nice) on drugs for terminal cancer, which have focused attention on those who do not survive,...
... www.osip.com - OSI Pharmaceuticals, Inc. (Nasdaq: OSIP) welcomes today"s announcement by the U.K."s National Institute for Health and Clinical Excellence (NICE) issuing Final Guidance recommending funding by the National Health Service (NHS) for...
...of the medicines that had previously been deemed too expensive to prescribe will be approved by the National Institute for Health and Clinical Excellence (Nice) early next year. The move is a major victory for campaigners, patients and cancer...
...called the The Health Care Comparative Effectiveness Research. The Institute is modeled on Britain's National Institute for Health and Clinical Excellence (NICE) which was established to compare the relative value of medical technology. The Institute has...
...Nov 2008 - 7:00 PST email to a friend printer friendly view / write opinions rate article The National Institute of Health and Clinical Excellence (NICE) has today published findings of its appeal panel around the use of adalimumab, etanercept and...
Timeline
You must have Javascript and Flash version 8+ enabled to see this content.
was said in:
22 hours ago from Pharmalot